Giusy L. Fratello

Giusy L. Fratello

Auto-generated profile, based on publicly available information

Giusy L. Fratello

University of Pisa

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2026 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
Giulia BononiGiulia Bononi
Giulia Bononi
GSGiulia Sibille
Giulia Sibille
Erika PlicantiErika Plicanti
Erika Plicanti
FTFabio Testori
Fabio Testori
GFGiusy L. Fratello
Giusy L. Fratello
Filippo MinutoloFilippo Minutolo
Filippo Minutolo
Endoplasmic reticulum (ER) oxidoreductases are promising targets for host-targeted antiviral agents (HTAs) because of their essential role in protein folding, including the maturation of viral proteins. Human protein disulfide isomerase family member A3 (PDIA3) is involved in the folding of N-glycosylated client proteins, including viral envelope proteins, making it an attractive but underexplored antiviral target. Here, we describe the discovery of a novel N-hydroxyindole-2-carboxamide class of PDIA3 inhibitors, exemplified by compound AV22 (1o), which effectively inhibits PDIA3 activity and exerts broad-spectrum antiviral activity against major human respiratory viruses. Mechanistic studies indicated that AV22 (1o) increased the release of non-infectious coronavirus particles and reduced disulfide bond formation in the coronavirus spike protein, indicating that its antiviral effect stems from interference with PDIA3 activity. This new class of HTAs provides promising leads for drug discovery targeting viral envelope protein maturation vulnerabilities and is suitable for developing new BSAs.